Accelr8 Announces Continuation of BACcel™ Collaboration
June 30 2011 - 5:55PM
Business Wire
Accelr8 Technology Corporation (NYSE Amex: AXK) announced
that the company agreed to extend its letter of intent with its
industry collaborator, based on prepaid R&D expenses, for one
month to July 31, 2011. The collaborator stated the companies’
joint intent to complete evaluation of Accelr8’s data and agree on
business terms for a formal business relationship and definitive
Business Agreement by July 31, 2011.
According to David Howson, Accelr8’s president, “In the last six
months, we’ve worked successfully with outside engineering
specialists to install fluid robotics and high-speed microscopy.
We’ve tested hundreds of patient specimens and keep increasing our
capacity. The higher capacity of the system has generated
substantial research data including the human specimen analyses.
This data volume necessitates the extension.”
About Accelr8
Accelr8 Technology Corporation (www.accelr8.com) is a developer of innovative
materials and instrumentation for advanced applications in medical
instrumentation, basic research, drug discovery, and bio-detection.
Accelr8 is developing a rapid analytical platform for infectious
pathogens, the BACcel™ system, based on its innovative surface
coatings, assay processing, and detection technologies. In
addition, Accelr8 licenses certain of its proprietary technology
for use in applications outside of Accelr8’s own products.
Certain statements in this news release may be “forward-looking
statements” within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Statements regarding future prospects and
developments are based upon current expectations and involve
certain risks and uncertainties that could cause actual results and
developments to differ materially from the forward-looking
statement, including those detailed in the company's filings with
the Securities and Exchange Commission. Accelr8 does not undertake
an obligation to publicly update or revise any forward-looking
statements, whether as a result of new information or future
events.
Accelr8 (AMEX:AXK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Accelr8 (AMEX:AXK)
Historical Stock Chart
From Jul 2023 to Jul 2024